Beirunning eye drops won the bid for the fourth batch of "national mining"
Release time:
2021-03-01
News from our newspaper # February , the fourth round of centralized national drug procurement was officially opened in Shanghai, and Berunning (Olopatadine Hydrochloride Eye Drops) of Jianfeng Pharmaceutical Co., Ltd. won the bid.
This "national procurement" was started on September 11 15 , involving 126 enterprises with 45 varieties 80 product specifications, including injection 8 , eye drops 3 , and the rest are oral preparations, showing a relatively fierce competition situation. Beirunning (Olopatadine Hydrochloride Eye Drops) of Jianfeng Pharmaceutical Company is a Class B variety of national medical insurance. As the first eye drop in China to pass the consistency evaluation, it has received extensive attention due to its unique efficacy of antagonizing histamine H1- receptor and stabilizing mast cell bidirectional anti-allergy, and finally won the bid successfully. Beirunning in the treatment of children with allergic conjunctivitis has good effect and fast effect, and will not cause significant mast cell degranulation, so it is safer to use and has almost no adverse reactions to ocular tissues. It is currently an ideal drug for the treatment of allergic conjunctivitis. The product
was approved for listing in 2019, and has not yet formed a market scale. The winning bid belongs to the new volume market, which is conducive to the rapid volume sales of products, which means that the pharmaceutical company is expected to rapidly expand the market space with the help of this centralized purchase, enhance the brand influence of the enterprise, and have a positive impact on the future business performance of the enterprise. (Xu Yuting)
More information
On the afternoon of June 9, Peak Cable Company organized all employees to learn fire fighting knowledge and conducted fire fighting and emergency escape drills. Since June, the subordinate enterprises of the company have organized training, learning and drills related to production safety according to their own characteristics and combined with the actual work. Safety production month series of activities carried out in an orderly manner.
2022
06-13
Spike Postdoctoral Research Papers on International Frontier Journals
Recently, good news came from the postdoctoral workstation of Jianfeng Pharmaceutical. Under the guidance of workstation mentor Jiang Xiaomeng, associate researcher Yang Xiaoxiao has made new progress in the treatment of alcoholic liver disease. The relevant research results "Roxadustat, a hypoxia-inducible factor 1a activator, attenuates both long- and short-term alcohol induced alcoholic liver disease" were published in the internationally renowned academic journal "Frontiers in Pharmacology. This journal is a frontier journal in the field of international pharmacy, mainly publishing academic papers and information on basic and clinical pharmacology, medicinal chemistry, pharmacology and toxicology.
2022
06-01
Daye Peak QC Achievements Won the Third Prize of Huangshi City
On May 7, Huangshi City Quality Strong City Working Committee organized a 2022 QC Results Conference. The QC project of "Technical Transformation of Ore Limestone Batching System" of Daye Peak Cement Company won the third prize.
2022
06-01
On April 28, Dalian Commodity Exchange held an online working meeting to announce the results of the 2021 excellent delivery warehouse and delivery warehouse excellent futures personnel selection, peak international trading company won the 2021 "excellent designated delivery warehouse" title, futures commissioner Ruan Weihang won the "excellent futures personnel" title.
2022
06-01
Cranberry extract combination identification detection method won the invention patent
After cranberry extract products were included in the "Zhejiang Province Key High-tech Product Development Project Plan" in 2021, Jianfeng Health Technology Company recently obtained an invention patent for the identification and detection method of cranberry extract. This new combined identification and detection method developed by Jianfeng Health identifies whether catechin or procyanidin B2 is added in cranberry extract by thin layer analysis, and then detects the unique A- type procyanidin and its chromatographic distribution in cranberry extract by high performance liquid chromatography, so as to improve the accuracy of product judgment. The identification method has the characteristics of accurate results and short detection time, which is of great significance to standardize the cranberry extract market and promote the healthy development of the industry, and has been unanimously recognized by peers.
2022
05-20
Daye Peak Manufacturing Department Won the Title of "Worker Pioneer" in Hubei Province
A few days ago, the manufacturing department of Daye Peak Cement Company was awarded the title of "Worker Pioneer" by the Hubei Provincial Federation of Trade Unions. Daye Jianfeng Manufacturing Department not only continued to actively explore and achieved good results in energy saving and consumption reduction, technological transformation, product quality process control, and economic responsibility system to guide management, but also improved Daye Jianfeng's overall operation level and won Huangshi City The seventh "Mayor Quality Award" created conditions and was fully affirmed by government departments at all levels.
2022
05-20
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page